John Overdeck Two Sigma Investments
John Overdeck is a co-founder of Two Sigma Investments, one of the world’s leading quantitative and technology-driven investment firms. Two Sigma applies data science, machine learning, and large-scale computing to markets across asset classes. Overdeck’s firm is a central reference point in discussions of modern systematic investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$297M |
| 2 |
Bank of America
BAC
|
+$249M |
| 3 |
Oracle
ORCL
|
+$247M |
| 4 |
Microsoft
MSFT
|
+$246M |
| 5 |
Snap
SNAP
|
+$243M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$260M |
| 2 |
Merck
MRK
|
+$260M |
| 3 |
S&P Global
SPGI
|
+$233M |
| 4 |
Occidental Petroleum
OXY
|
+$221M |
| 5 |
Walmart Inc
WMT
|
+$211M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.21% |
| 2 | Healthcare | 13.54% |
| 3 | Financials | 11.06% |
| 4 | Industrials | 10.41% |
| 5 | Consumer Discretionary | 7.35% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2101
Ponce Financial Group
PDLB
$494M
| $226K | ﹤0.01% |
24,500
-90,536
| -79% | -$880K |
|
2102
Microvast
MVST
$298M
| $224K | ﹤0.01% |
+100,875
| New | +$433K |
|
|
AERI
2103
DELISTED
Aerie Pharmaceuticals
AERI
| $224K | ﹤0.01% |
29,829
-25,138
| -46% | -$177K |
|
2104
LSI Industries
LYTS
$719M
| $222K | ﹤0.01% |
35,914
+10,097
| +39% | +$64.8K |
|
2105
NextDecade
NEXT
$1.96B
| $222K | ﹤0.01% |
49,909
-83,525
| -63% | -$518K |
|
|
ZEPP
2106
Zepp Health
ZEPP
$73.2M
| $220K | ﹤0.01% |
29,750
+4,051
| +16% | +$37.3K |
|
|
SNCE
2107
DELISTED
Science 37 Holdings, Inc. Common Stock
SNCE
| $220K | ﹤0.01% |
+5,477
| New | +$400K |
|
|
BFS
2108
Saul Centers
BFS
$844M
| $219K | ﹤0.01% |
+4,656
| New | +$230K |
|
|
TCS
2109
DELISTED
THE CONTAINER STORE GROUP, INC.
TCS
| $219K | ﹤0.01% |
+2,347
| New | +$266K |
|
|
RCM
2110
DELISTED
R1 RCM Inc. Common Stock
RCM
| $219K | ﹤0.01% |
10,472
-228,572
| -96% | -$5.19M |
|
|
CVLY
2111
DELISTED
Codorus Valley Bancorp Inc
CVLY
| $217K | ﹤0.01% |
9,620
-10,038
| -51% | -$229K |
|
2112
Relmada Therapeutics
RLMD
$489M
| $216K | ﹤0.01% |
11,351
+851
| +8% | +$18.6K |
|
|
RAPT
2113
DELISTED
RAPT Therapeutics
RAPT
| $215K | ﹤0.01% |
1,475
-8,374
| -85% | -$1.12M |
|
2114
Western New England Bancorp
WNEB
$278M
| $215K | ﹤0.01% |
28,807
-1,908
| -6% | -$15.9K |
|
|
DRRX
2115
DELISTED
DURECT Corp
DRRX
| $213K | ﹤0.01% |
44,567
+7,217
| +19% | +$34.5K |
|
2116
HBT Financial
HBT
$1.31B
| $213K | ﹤0.01% |
11,939
-4,855
| -29% | -$85.3K |
|
2117
Methode Electronics
MEI
$498M
| $213K | ﹤0.01% |
+5,743
| New | +$248K |
|
2118
Avista
AVA
$3.18B
| $212K | ﹤0.01% |
+4,863
| New | +$209K |
|
2119
Third Coast Bancshares
TCBX
$760M
| $212K | ﹤0.01% |
+9,666
| New | +$225K |
|
2120
CALL
VanEck Gold Miners ETF
GDX
$32.2B
| $211K | ﹤0.01% |
+7,700
| New | +$260K |
|
|
2121
PUT
VanEck Gold Miners ETF
GDX
$32.2B
| $211K | ﹤0.01% |
+7,700
| New | +$260K |
|
2122
Stoke Therapeutics
STOK
$2.09B
| $211K | ﹤0.01% |
16,003
+4,761
| +42% | +$72.3K |
|
|
SUP
2123
DELISTED
Superior Industries International
SUP
| $210K | ﹤0.01% |
53,151
-37,483
| -41% | -$147K |
|
|
TGI
2124
DELISTED
Triumph Group
TGI
| $210K | ﹤0.01% |
15,765
-68,223
| -81% | -$1.29M |
|
|
EVOP
2125
DELISTED
EVO Payments, Inc. Class A Common Stock
EVOP
| $210K | ﹤0.01% |
8,943
-51,255
| -85% | -$1.17M |
|
Similar funds
John Overdeck's Q2 2022 Portfolio in Review
As of Q2 2022, John Overdeck held 3,177 positions worth $30.3B, down 11% from $33.9B the previous quarter. Its ten largest holdings account for 8.2% of the portfolio.
John Overdeck deployed $2.33B of net new capital in Q2 2022, opening 628 new positions and adding to 764 existing holdings. Its largest new stake was Meta Platforms (Facebook): 1,541,482 shares worth $249M.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Merck, an estimated $260M trimmed.
- John Overdeck's largest Q2 2022 buy was Meta Platforms (Facebook): 1,541,482 shares worth $249M.
- John Overdeck added most to Bank of America in Q2 2022, an estimated $249M increase.
- John Overdeck's biggest Q2 2022 reduction was Merck, cutting an estimated $260M.
- John Overdeck fully exited Tesla in Q2 2022, selling an estimated $260M.
- John Overdeck's ten largest holdings make up 8.2% of its $30.3B portfolio in Q2 2022.
- John Overdeck opened 628 new positions and closed 730 in Q2 2022.
- John Overdeck's portfolio value fell 11% quarter-over-quarter to $30.3B.
Based on Two Sigma Investments's 13F filing for Q2 2022, filed 15 Aug 2022.